Impact of CD4 T Cell Counts on the Immunogenicity and Safety of the Recombinant Zoster Vaccine in People Living with HIV.
OBJECTIVES People living with HIV (PLWH) are at increased risk for herpes zoster. This study aimed to evaluate and compare the immunogenicity and safety of the recombinant zoster vaccine (RZV) in PLWH across low and high CD4 counts, and in participants living without HIV (PLWoH). METHODS In this non-randomized clinic...